Financial Incentives to Improve Medication Adherence

Financial Incentives to Improve Medication Adherence: a Pilot Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04191876

Enrollment

Registered

2019-12-10

Start date

2019-11-01

Completion date

2022-03-02

Last updated

2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Depression, Schizo Affective Disorder, Schizophrenia

Keywords

financial incentives, medication adherence, severe mental illness

Brief summary

Medication adherence is a challenge in all of medicine and is associated with multiple negative outcomes. Strategies to better measure and enhance adherence to medication are urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral economics-based approaches have emerged as a promising tool to address this unmet need, but its effectiveness in oral antipsychotic treatment remains to be assessed. For this project, investigators will use an app that offers financial incentives to increase compliance for patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project to assess feasibility of offering financial incentives to improve medication adherence in severe mental illness.

Interventions

OTHERWellth - Financial Incentives

Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Psychiatric patients with suspected or confirmed poor oral medication adherence. 2. Age 18-80 years old 3. English speaking, since the app being used is only available in English 4. Owning a Smartphone, since the app requires a Smartphone to work 5. Willing and able to participate.

Exclusion criteria

1. Acute anger to self or others as per investigator assessment 2. Unwilling or unable to participate

Design outcomes

Primary

Measure	Time frame	Description
Change in medication adherence rate	Between baseline and study completion (10 weeks)	Adherence rate will be measured as pills missed/pills prescribed

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026